Metabolic syndrome, indicated by insulin resistance/hyperinsulinemia, obesity, central obesity, atherogenic dyslipidemia, and hypertension, contributes to atherosclerotic cardiovascular disease. However, it is controversial whether the indicators of metabolic syndrome are related to subclinical atherosclerosis collectively or individually. Whether there is any gender-based difference in the mechanisms of metabolic syndrome-induced atherosclerosis progression is also unknown. Two models were compared in this study. Model 1 assumes that a latent factor, metabolic syndrome per se, impacts subclinical atherosclerosis (collective effects model); Model 2 assumes the effect of the syndrome is mediated through its indicators (individual effects model). Data were obtained from the Los Angeles Atherosclerosis Study. The cohort consists of 573 adults (age, 40-60 years) who were asymptomatic for cardiovascular disease. Subclinical atherosclerosis was assessed by measuring common carotid artery intima-media thickness (CCA-IMT) using B-mode ultrasound. Three examinations were completed at 1.5-year intervals from 1995-1999. The analyses were performed with SAS 8.2 and AMOS 4.0. The results showed that atherogenic effects of metabolic syndrome were mediated through its indicators; there were gender-based differences in the mechanisms of metabolic syndrome-induced atherosclerosis. Central obesity was significantly associated with the baseline IMT for men only, whereas triglycerides were significantly associated with the progression of IMT for women only. Systolic blood pressure was significantly associated with the baseline and progression for both men and women. However, fasting insulin was not found to be significantly associated with the baseline and progression of IMT in the multivariate model, although it was significantly associated with other components of metabolic syndrome. J Atheroscler Thromb, 2006; 13: 46-54.
Introduction
Metabolic syndrome (MSynd) is a clustering of metabolic, anthropometric and hemodynamic disorders, including insulin resistance/hyperinsulinemia, progressive glucose intolerance, atherogenic dyslipidemia [increased triglycerides, decreased high density lipoprotein cholesterol (HDL-C), increased small dense low-density lipoprotein particles obesity (central and general), and hypertension. Metabolic syndrome has also been proposed to be a cluster of important risk factors besides low-density lipoprotein cholesterol (LDL-C) in the development of atherosclerosis (1) . The presence of metabolic syndrome is associated with increased coronary heart disease (CHD) events, cardiovascular mortality, and reduced survival (2) (3) (4) . Metabolic syndrome is also reported to be predictive of subclinical atherosclerosis (5) .
In this study, "metabolic syndrome" is a latent construct depicting the clustering of cardiovascular risk factors, rather than any operative definitions categorizing individuals as having or not having MSynd based on major components (1, 6) . To be called a syndrome, all proposed components should be highly correlated with the central concept (hallmark of the entity). Supposing that all components share a common underlying factor, their intercorrelations should be high, too. In the case of MSynd, insulin resistance with resulting hyperinsulinemia is commonly assumed to be the core feature and the fundamental cause (6, 7) . Factor analysis has been used to identify whether one or more "factors" unite the components of metabolic syndrome (13) . The derived factor scores were used to associate the syndrome with cardiovascular risk. MSynd is assumed to confer cardiovascular risk collectively in this type of analysis. However, to our knowledge, no study has been performed to examine whether this hypothesis is true.
The high intercorrelation among its components (indicators) of MSynd means that one component is correlated with outcome in a bivariate analysis, yet the correlation becomes non-significant when other components of MSynd are entered simultaneously in a conventional multivariate analysis. A method that would adequately estimate the collective effects of MSynd is necessary to account for this clustering. In addition, studies show that the impact of the components of MSynd on subclinical atherosclerosis differs between men and women (7, 8) . No longitudinal data have yet been used to examine the sex differences in this regard.
This study is designed to examine whether a "metabolic syndrome" latent factor affects baseline and progression of subclinical atherosclerosis; which model fits the data better, collective-effect model or individual-effect model. The longitudinal data also allowed for identifying unique factors contributing to the baseline and progression of atherosclerosis. Identification of the distinct factors contributing to each facilitates the partitioning of chronic (by cross-sectional association) and short-term (by three-year progression) impacts exerted by metabolic syndrome. Sex-related differences in the associations were also examined.
In this study, common carotid arterial intima-medial thickness (CCA-IMT) measured by B-mode ultrasound was used as a surrogate measure of subclinical atherosclerosis (9) . CCA-IMT is a reliable measure of arterial wall thickness (10) in prospective studies. CCA-IMT and progression of IMT have been shown to predict coronary heart disease and ischemic stroke (11, 12) .
Methods

Subjects
The initial Los Angeles Atherosclerosis Study (LAAS) cohort of 573 adults (men, n = 304, age 40-60 yrs; women, n = 269, age 45-60 yrs) was recruited from random samples of employees from a local utility company. This cohort had no history of cardiovascular disease or stroke. The baseline examination was completed in 1995. Two follow-up examinations were completed at 1.5-yr intervals. Out of the selected sample, about 87% (232 women and 268 men) completed at least one follow-up examination. Fully informed consent was obtained from all the participants. The study protocol was approved by the Institutional Review Board of the Keck School of Medicine at the University of Southern California.
Carotid IMT measurement
CCA-IMT was assessed using high-resolution B-mode ultrasound (ATL scanner, model UM4 + , with 7.5 MHz linear transducer). The IMT was measured at the far wall of the artery in a 1 cm section of the common carotid 0.25 cm proximal to the bulb. Participants were scanned in two body positions (supine and lateral) and on two sides (right and left). Up to 8 frames were processed for each participant. Procedures for image acquisition and processing were reported previously (10).
Metabolic syndrome variables
Fasting blood samples were collected by venipuncture and were frozen at -70°C. Total serum cholesterol, HDL-C and triglycerides were measured by an autoanalyzer with the Roche direct HDL-C method which meets the 1998 NIH/NCEP goals for acceptable performance (19) . Low-density lipoprotein cholesterol (LDL-C) was estimated for fasting samples only (fasting time longer than 8 hours prior to examination) (20) . The plasma glucose concentration was measured by the glucose oxidase method with a Beckman glucose analyzer (Beckman Instruments, Fullerton, CA). Plasma insulin was determined by a specific radioimmunoassay with reagents from Linco Research (St. Louis, MO) with a detection limit of 2 microU/ml (12 pmol/l) and interassay coefficient of variation of 6-8%.
Systolic blood pressure (SBP) and diastolic blood pressure (DBP) were measured by standard sphygmomanometer and recorded to the nearest digit. Height, weight, sagittal abdominal diameter, and transverse abdominal diameter were measured. BMI (kg/m 2 ) was calculated as weight (kg) divided by height squared (m 2 ). The sagittaltransverse abdominal diameter ratio was calculated from the two diameters.
Statistical analysis
Two structural equation models were constructed. In the first model, the MSynd per se is assumed to be associated with subclinical atherosclerosis directly (M1: MSynd → IMT). In the second model, an assumption is made that the effect of the MSynd is mediated through its indicators (MSynd → its indicators → IMT). Analyses were performed using SAS 8.2 (SAS Institute Inc., Cary, NC) and a structural equation modeling program Amos 4.0 (13).
Serum triglycerides, fasting insulin, and fasting glucose were natural log-transformed due to right-skewed distributions. Initial estimates of association between variables were based on Pearson's product-moment correlations. A measurement model provides guidance for selection of optimal indicators for the latent construct. The measurement model for MSynd was established separately by gender at baseline. The variables selected to be the indicators of the MSynd had to fulfill two criteria: 1) they must be among the most frequently hypothesized components of the MSynd and 2) the standardized factor loading must be > 0.40 in confirmatory factor analyses (Factor loadings of > 0.4 indicating at least 15% of variance shared with the factor are considered definitive of the factor intercorrelation) (14) .
Latent growth modeling is a special type of structural equation modeling (25) . It provides a model to analyze the longitudinal individual change of a variable. The common carotid intima-media thickness (IMT) over three examinations was modeled to generate two factors, i.e., intercept (baseline IMT) and slope (progression rate of IMT per year). The regression weight for the slope was 0, 1.5, and 3 to reflect the average interval (years) between examinations. Because we used metabolic syndrome variables at baseline, the whole framework of the modeling was designed to examine the cross-sectional (baseline) and longitudinal (progression) relations between MSynd and IMT.
Structural equation modeling (SEM) in AMOS incorporates a measurement model (for MSynd) and a latent growth model (for IMT). LDL-C was controlled as a covariate (Fig. 1) . In order to handle missing data, the parameter estimates were obtained by full information maximum likelihood (FIML) estimation (13) . Measures of model fit included the ratio of minimum value of the discrepancy function (chi-square distribution) to its degree of freedom (Cmin/df), comparative fit index (CFI), and root mean square error of approximation (RMSEA) (13) . The ratio of Cmin/df is supposed to be close to 1 for a correct model; a RMSEA value of about 0.05 or less indicates a close fit of the model; a CFI value close to 1 indicates a good fit of the model. The release of an equality constraint across genders was guided by the chisquare difference of two models, one with the constraint and the other without. The constraint was released if the chi-square difference was greater than 3.84.
Results
Descriptive statistics
The sample consisted of about 56% non-Hispanic whites, 29% Hispanics, 5% blacks, 7% Asians, and 3% others. Men were younger, had higher levels of total serum cholesterol, LDL-C, triglycerides, fasting plasma in- IMT: intima-medial thickness, HDL-C: high-density lipoprotein cholesterol, LDL-C: low-density lipoprotein cholesterol, †:Genderbased differences in continuous and categorical variables were determined using an analysis of covariance (controlled for age) and the X 2 test of significance, respectively, §:The logarithmically transformed mean and its standard deviation are shown. 1 †: p < 0.10, The partial Pearson's correlations were adjusted for age and ethnicity for V1 to V9. The partial Pearson's correlations were adjusted for age, ethnicity, and body height for V10 vs. V1 to V9. The correlation coefficients were significant at p < 0.05 except otherwise indicated. The correlations for men are shown in the upper diagonal. BMI: body mass index, Sag2Tr: Sagittal-transverse abdominal diameter ratio, SBP: systolic blood pressure, HDL-C: high-density lipoprotein cholesterol, DBP: diastolic blood pressure, LDL-C: low-density lipoprotein cholesterol, IMT: intima-medial thickness.
sulin, fasting plasma glucose, and blood pressure, and lower levels of HDL-C than women. Baseline IMT was greater in men than in women (Table 1) .
Correlation analysis and measurement model
The partial Pearson's correlation matrices for women and men are shown in Table 2 . A noticeable gender-based difference was observed in the correlation between fast-ing plasma glucose and other variables. The fasting plasma glucose concentration is significantly correlated with insulin, HDL-C, blood pressure, and IMT in women but not in men. In further multivariate analyses, fasting glucose was not significantly related to IMT for either men or women. Furthermore, the standardized factor loading for fasting glucose did not meet the criteria (e.g. > 0.40) in the confirmatory factor analysis. For the purpose of parsimony, fasting glucose was not considered an indicator for metabolic syndrome in further analyses. SBP and DBP correlated with other variables in a similar manner and there was a relatively high correlation between these two variables (r = 0.69 for both men and women, p < 0.001). Again for the purpose of parsimony, only SBP was included as an indicator for MSynd.
The final measurement model thus included the fasting insulin level (indicating insulin resistance), BMI (indicating general obesity), sagittal-transverse abdominal diameter ratio (indicating central adiposity), serum HDL-C and triglycerides (indicating dyslipidemia), and SBP (indicating high blood pressure). The model fit was good (X 2 15 = 12.6, p = 0.63, CFI = 1.00, RMSEA = 0.000). The parameter estimates and standardized regression weights for the measurement model are shown in Table 3 .
Latent growth modeling
Three consecutive IMT measurements manifested a significant linear increase across three years. The means (standard deviation) of the IMT in women were 651.7 (84.1), 663.0 (89.5), and 672.6 (97.3) µm. The means (standard deviation) of the IMT in men were 676.0 (102.7), 692.1 (117.8), and 705.7 (127.7) µm. The correlation between the baseline and the progression of IMT was stronger in men (r = 0.57, p = 0.004) than in women (r = 0.31, p = 0.07). All the parameters were significant at p < 0.05. Beta: standardized regression weight, BMI: body mass index, Sag2Tr: sagittal-transverse abdominal diameter ratio, HDL-C: high-density lipoprotein cholesterol, SBP: systolic blood pressure. †: The equality constraints for the factor loadings across gender were retained by factor invariance tests. Thus the estimates were equal across genders. IMT: intima-medial thickness, Beta: standardized regression weight, MSynd: metabolic syndrome, LDL-C: low-density lipoprotein cholesterol. †: For model simplicity, the parameters which were not significant at p < 0.10 for either women or men were eliminated from the specification. §: The equality constraints for the regression weight across gender were retained by the factor invariance test.
Structural equation modeling
In M1, the latent factor of metabolic syndrome was significantly related to both the baseline and progression of IMT (p < 0.05) ( Table 4 ). Serum LDL-C was significantly related to IMT at baseline in men but not in women. MSynd and serum LDL-C were significantly correlated (r = 0.271, p < 0.0001 for women and r = 0.16, p < 0.05 for men).
In M2 (Table 5) , SBP was significantly associated with a greater baseline and progression of IMT in both women and men. Central adiposity (indicated by the ratio of sagittal-transverse abdominal diameter) was significantly associated with a greater baseline IMT in men, whereas general obesity (indicated by BMI) was significantly associated with a greater baseline IMT in women. Serum triglycerides were significantly associated with the progression of IMT in women only. Most noticeably, the effects of HDL-C on the progression of IMT were opposite for women versus men. High HDL-C was directly associated with the progression of IMT in women, whereas HDL-C was inversely associated with the progression in men. The model fit for M2 was ideal (X 2 27 = 22.9, p = 0.69, CFI = 1.000), and was superior to M1 (the difference of X 2 was 119.4, the difference in the degree of freedom was 32, p < 0.001) (Table 6 ). Furthermore, the significant direct effect of MSynd on IMT in M1 disappeared after the mediated effects of the indicators were taken into account in M2. These results undermined the as- §: For model simplicity, the parameters which were not significant at p < 0.10 for either women or men were eliminated from the model specification. sumption that an underlying "metabolic syndrome" latent factor causes atherosclerosis directly and on the other hand, justified a mediation model, i.e., the effects of metabolic syndrome on IMT were completely mediated through its indicators. In addition there was no significant direct path from fasting insulin to IMT in M2. It is speculated that the effect of hyperinsulinemia on IMT may be mediated through other manifestations of the metabolic syndrome.
Discussion
Although LDL-C is a critically important factor in the development of atherosclerosis, many patients suffering from cardiovascular disease have normal cholesterol levels (15) . Therefore, attention has been drawn to other modifiable cardiovascular risk factors such as the MSynd.
The cluster of cardiovascular risk factors defining MSynd has been frequently identified in the literature, but the existence and nature of a discrete MSynd remains controversial. A consistent observation was that more than one factor was identified. A central factor of MSynd, which is characterized by hyperinsulinemia, dyslipidemia, and obesity, was identified in an exploratory factor analysis (16) . Blood pressure did not cluster with other metabolic syndrome variables in most such analyses (16, 17) . However, there was strong evidence that essential hypertension is highly correlated with insulin resistance (31) . This apparent paradox reflects the limitation of the exploratory factor analysis. In most such analyses, both SBP and DBP were pooled with other variables. Given that these two variables are highly correlated, it is not surprising that these two variables form a separate blood pressure factor. Therefore, the result of multiple factors from previous exploratory factor analyses does not necessarily indicate independent pathogenic causes underlying metabolic syndrome; the conclusion that blood pressure is not related to insulin resistance may not be relevant. To avoid confusion, it is probably more appropriate to include only one indicator of hypertension (e.g., SBP) in a confirmatory factor analysis as did in this study.
The result that fasting glucose did not cluster with other components of metabolic syndrome (especially in men) accords with previous reports (16) . This result is not unanticipated because the fasting glucose concentration is determined by not only insulin resistance, but also pancreatic insulin secretion (18) .
Fasting insulin concentration was not directly related to the baseline and progression of IMT in the SEM model. This may be in part due to a large measurement variation of insulin compared with other metabolic indicators (not tested though). Another explanation is, assuming insulin resistance and consequent hyperinsulinemia is the underlying pathophysiologic mechanism for the MSynd (19) , its relation with IMT is probably mediated through other components of the Msynd. In comparison, the results obtained from conventional multivariate analyses in the literature varied with regard to the direct association between fasting insulin and cardiovascular risk, with fasting insulin as a predictor (20) (21) (22) or not (23, 24) for cardiovascular disease independent of other cardiovascular risk factors. Although the disparate findings may be attributed to differences in the population (e.g., age, gender, ethnicity) and outcome measures, the conventional multivariate analysis may unintentionally obscure the complex intercorrelations between risk factors (39). On the other hand, although fasting insulin has been identified to be strongly associated with all other main components of the MSynd, it is still unclear whether insulin resistance and resultant hyperinsulinemia represent the fundamental cause of the metabolic abnormalities. There are a number of other putative candidates for the fundamental mechanism behind the origin of metabolic syndrome. For example, central adiposity was found to contribute to metabolic syndrome independent of insulin resistance (25, 26) .
The advantage of M2 over M1 indicated that the Msynd actually exerts atherogenic effects through individual components (manifestations). The setup of model 2 was similar to a conventional regression analysis. The sole difference was that the intercorrelation of the variables becomes explicit in the SEM model rather than implicit. A limitation of conventional multivariate analysis is the structural assumption of equal proximity of all potential factors to the outcome (27) . Equal proximity may not apply to the MSynd variables leading to atherosclerosis. For example, hyperinsulinemia may be a more distant causal factor than other variables and thus tends to be dismissed by equal proximity modeling (28) . In contrast, structural equation modeling is more flexible in testing alternative hypotheses on the proximity of risk factors. However, complicated causal hypotheses should be tested by a longitudinal design.
The strength of association between the MSynd variables and IMT differs for middle-age women versus men. Some of the findings are consistent with other studies (29, 30) . In the multivariate analysis, central obesity was significantly associated with the baseline IMT for men only, whereas triglycerides were significantly associated with the progression of IMT for women only. SBP was significantly associated with the baseline and progression of IMT for both men and women. The fact that the correlation between the baseline and progression of IMT was stronger for men than for women may indicate that middle-aged men were at more advanced stages of atherosclerosis with an accelerated progression. This finding is consistent with reports that the onset of cardiovascular disease generally occurs earlier in men than in women. Considering that pathologically distinct processes exist during the development of atherosclerosis (31) , the gender differences may also implicate different atherogenic mechanisms in different stages of atherosclerosis.
The effect of HDL-C on the progression of IMT was opposite for women versus men. In brief, although HDL-C levels at the lower end contribute to the MSynd, a HDL level at the higher end fails to protect women effectively from the progression of atherosclerosis. In other words, the anti-atherogenic function of HDL diminished over time for women. This important finding requires further verification in other prospective studies.
Interpretation for relating the diagnosis of MSynd per se to any cardiovascular outcome needs to be cautioned (32, 33) . This study treated the MSynd as a continuum with diverse profiles among the study sample. It demonstrated that the relative contribution of each component to subclinical atherosclerosis varies; the atherogenic effects of the metabolic syndrome are mediated through its indicators by either affecting the baseline or accelerating the progression of IMT. Furthermore, there were gender differences in atherogenic pathways caused by the metabolic syndrome.
These findings have important implications in the etiology, prevention, and treatment of atherosclerosis. Improvements in individual components which exert significant atherogenic effects could deter the progression of atherosclerosis. In addition, this study also showed that structural equation modeling is a useful tool in disentangling complicated associations between metabolic syndrome and progression of subclinical atherosclerosis.
